| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 243,576 | 282,656 | 324,804 | 393,125 | | Cost of Revenue | (13,695) | 208,814 | 216,887 | 249,424 | | | Gross Profit | 257,271 | 73,842 | 107,917 | 143,701 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 139,730 | 26,938 | 29,469 | 39,839 | | Non Recurring | 92,763 | 1,215 | (93,978) | 186,771 | | Others | 40,977 | 44,890 | 43,881 | 47,821 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,199) | 799 | 128,545 | (130,730) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 873 | (1,824) | 2,305 | 4,097 | | Earnings Before Interest And Taxes | (12,846) | 91 | 133,322 | (102,107) | | Interest Expense | 10,933 | 10,903 | 11,372 | 9,600 | | Income Before Tax | (23,779) | (10,812) | 121,950 | (111,707) | | Income Tax Expense | (1,850) | (2,991) | (1,312) | (32,162) | | Minority Interest | (180) |
-
|
-
| 12,234 | | | | Net Income From Continuing Ops | (16,041) | (7,821) | 123,262 | (79,545) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,109) | (7,821) | 123,262 | (79,545) | | Preferred Stock And Other Adjustments | 2,485 | (973) | (1,512) |
-
| | | Net Income Applicable To Common Shares | ($19,624) | ($8,794) | $121,750 | ($79,545) |
|
0.63% Nasdaq 
0.03%
Income Statement
